Description

Unlock new possibilities in cellular studies with our premium grade CJC-1295 fortified with DAC (Drug Affinity Complex). This synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) is engineered to overcome the limitations of standard peptides, offering researchers a stable and long-acting tool for investigation.

The DAC Difference
Native GHRH has a very short half-life in research environments, often lasting only minutes. By adding the Drug Affinity Complex, CJC-1295 binds to circulating serum albumin. This crucial modification significantly extends its half-life to several days, allowing for sustained stimulation of pituitary receptors rather than short, pulsatile spikes.

This product is essential for researchers investigating long-term hormonal signaling pathways, metabolic processes, and cellular recovery mechanisms without the variable of frequent re-administration.

Key Features & Specifications:

Sequence: CJC-1295 modified with Drug Affinity Complex.

Purity: ≥98% (determined by HPLC).

Format: Sterile-filtered, lyophilized (freeze-dried) powder for maximum stability.

Mechanism: Selective agonist for the GHRH receptor with extended duration of action.

Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human ingestion, diagnostic, therapeutic, or clinical procedures.